JUL 03, 2018 4:22 AM PDT

Here's a Virus that Boosts the Immune System

WRITTEN BY: Kara Marker

There’s a new therapeutic approach to boosting the weakened immune system that develops naturally with age, but it’s anything but conventional. A new study from the University of Arizona suggests that a virus can strengthen the immune system. For now, the research has been done in mice, but human clinical trials are not too far away.

Cytomegalovirus infection of a lung cell. Credit: CDC Public Health Image Library

The pathogen under the spotlight in the present study is cytomegalovirus (CMV), a common virus that affects people of all ages.

Once a person is infected, they are infected for life, but they usually show no signs or symptoms. Usually those who do develop symptoms as a result of CMV exposure are those people with weakened immune systems, including babies and the elderly.

"CMV doesn't usually cause outward symptoms, but we still have to live with it every day since there's no cure," explained one of the study’s leaders, Megan Smithey, PhD. "Our immune system always will be busy in the background dealing with this virus." In the new study, Smithey and her team infect old mice with CMV.

Their theory was that CMV would make the mice vulnerable to other infections because the virus was “using up resources and keeping the immune system busy.” Their study proved Smithey’s theory wrong.

Instead of weighing the mice down, CMV infection helped mice resist infection from listeria, a foodborne pathogen commonly present in improperly processed deli meats and unpasteurized milk products.

In addition to witnessing a stronger immune response to listeria as a result of CMV infection, after a closer look, researchers saw that the mice had a diverse supply of T cells, a population of cells vital to the adaptive immune response. Diversity in the T cell population indicates an increased ability to response to pathogenic invasions.

This finding challenges the long-held belief that T cell diversity decreases with age, leading to a weakened immune system. Instead, the researchers’ new hypothesis is that the T cell population is sustained throughout aging, but “recruiting them to the battlefield” becomes more difficult. In this case, CMV infection seemed to be the key to unlocking T cell power even in older populations.

Now researchers are launching a new study to uncover how CMV improves the immune system, with the hopes that they can harness this ability or even mimic it.

The present study was published in the journal Proceedings of the National Academy of Sciences.

Sources: Centers for Disease Control and Prevention, Mayo Clinic, University of Arizona Health Sciences

 

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
NOV 11, 2021
Immunology
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
NOV 11, 2021
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
Global vaccination efforts continue in the backdrop of the ongoing pandemic. However, new studies demonstrate how severa ...
DEC 14, 2021
Immunology
Eye Immunity Redefined: Immune Cells Do Enter the Lens After All
DEC 14, 2021
Eye Immunity Redefined: Immune Cells Do Enter the Lens After All
The eyes may be the windows to the soul, but they are also vulnerable access points for environmental pathogens. What&rs ...
JAN 07, 2022
Health & Medicine
Israel Approves Fourth Dose of COVID-19 Vaccine
JAN 07, 2022
Israel Approves Fourth Dose of COVID-19 Vaccine
While third doses are being approved for adults in countries worldwide, Israeli citizens are already receiving a fourth. ...
JAN 13, 2022
Health & Medicine
Studies Confirm Omicron Itself, Not Previous Immunity From Infections or Vaccines, Is Responsible for Milder Symptoms
JAN 13, 2022
Studies Confirm Omicron Itself, Not Previous Immunity From Infections or Vaccines, Is Responsible for Milder Symptoms
Despite initial fears last November that genetic changes to the Omicron variant might spell disaster for humans, rodent ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
Loading Comments...